Candriam S.C.A. - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$8,889,000
-5.3%
67,551
-63.6%
0.07%
-20.5%
Q3 2020$9,384,000
+6.0%
185,7210.0%0.09%
-5.4%
Q2 2020$8,854,000
-8.1%
185,721
+8.1%
0.09%
-13.1%
Q1 2020$9,636,000
-2.2%
171,7550.0%0.11%
+0.9%
Q4 2019$9,857,000
+25.1%
171,755
-21.6%
0.11%
+1.9%
Q3 2019$7,877,000
-21.2%
219,000
-32.2%
0.10%
-16.8%
Q2 2019$9,995,000
+0.3%
323,000
-24.0%
0.12%
-2.3%
Q1 2019$9,967,000
+399.6%
425,000
+193.1%
0.13%
+312.9%
Q4 2018$1,995,000145,0000.03%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders